All Industries

Top Genomics Companies

103 Genomics companies, sorted by total funding raised.

AkouosAcquired

Akouos is a biotechnology company focused on restoring and preserving hearing.

Boston, United States51–200Biotech, Therapeutics
Series B·$162.5M·Mar 2020
Genome Medical

Telehealth genetic counseling and test-support for patients, providers, and life-sciences partner...

South San Francisco, United States51–200Digital Health, Genomics
Series D·$158.3M·Oct 2024
Avencell

Clinical-stage biopharma developing switchable and allogeneic CAR‑T cell therapies for hard-to-tr...

Watertown, United States51–200Biotech, Genomics
Grant·$152.0M·Jun 2025
Clear Labs

Clear Labs provides food analytics while standardizing molecular food quality the global molecula...

San Francisco, United States51–200Food & Beverage, Genomics
Series D·$150.2M·Dec 2024
Ideaya BiosciencesIPO

Clinical-stage precision medicine oncology company developing targeted therapeutics using molecul...

South San Francisco, United States201–500Biotech, Drug Discovery
Series A·$140.0M·Jul 2024
Pretzel Therapeutics

Develops therapeutics that restore mitochondrial function for rare and common diseases using geno...

Waltham, United States11–50Biotech, Drug Discovery
Venture Unknown·$131.8M·Aug 2024
OmniomeClosed

Develops a short-read DNA sequencing platform (Sequencing by Binding) offering high accuracy for ...

San Diego, United States51–200Biotech, Genomics
Series C·$120.0M·Jan 2020
MISSION BIO INC

R&D company with 7 SBIR/STTR awards from Department of Health and Human Services, National Scienc...

SOUTH SAN FRANCISCO, United States1–10Biotech, Healthcare
Series C·$110.0M·Aug 2020
PacBioIPO

Developer and manufacturer of high-accuracy long-read DNA sequencing systems and consumables for ...

USA, United States501–1000Biotech, Genomics
Series F·$109.0M·Jul 2010
Singular GenomicsAcquired

Develops high-throughput spatial multiomics sequencing platforms and services for research and cl...

La Jolla, United States201–500Genomics, Life Sciences
Venture Unknown·$104.0M·Feb 2021
Variantyx

Molecular diagnostics lab providing whole-genome-based genetic testing for rare disorders, reprod...

Boston, United States51–200Diagnostics, Genomics
Series D·$100.0M·Apr 2024
EmbarkClosed

Public transit apps. Acquired by Apple in 2013.

Boston, United States1–10Biotech, Genomics
Series B·$91.1M·Jul 2021
Precision BioSciencesIPO

Clinical-stage gene editing company developing in vivo therapies using its proprietary ARCUS geno...

Durham, United States51–200Biotech, Gene Editing
Venture Unknown·$75.0M·Jun 2022
Kernal Biologics

Kernal is creating mRNA 2.0 therapies that work in specific cells

Cambridge, United States11–50Artificial Intelligence, Biotech
Grant·$73.0M·Oct 2025
Foundation MedicineAcquired

Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...

Cambridge, United States1001–5000Diagnostics, Genomics
Series A·$58.5M·Nov 2011
Moonwalk Biosciences

Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease usi...

South San Francisco, United States11–50Biotech, Drug Discovery
Seed·$57.0M·Jan 2024
VeracyteIPO

Veracyte is a global cancer diagnostics company that provides genomic tests to help clinicians di...

South San Francisco, United States501–1000Biotech, Diagnostics
Series C·$56.3M·Jun 2013
Seqera Labs

Seqera builds the bioinformatics platform powering Nextflow, enabling life sciences teams to run ...

Barcelona, Spain51–200Biotech, Genomics
Series B·$55.7M·May 2025
Helix Nanotechnologies

Next-generation mRNA platform to solve cancer, COVID and climate.

Boston, United States11–50Artificial Intelligence, Biotech
Series A·$45.0M·Mar 2022
Glyphic Biotechnologies

Developing a single-molecule, high-throughput proteome sequencing platform (ProSE) for researcher...

Berkeley, United States11–50Biotech, Genomics
Series A·$42.5M·Sep 2025
Arpeggio Bio

Arpeggio Bio develops drugs targeting transcription factors using AI…

Boulder, United States11–50Biotech, Drug Discovery
Series B·$40.2M·Nov 2025
Genomenon

Top startup/tech company to watch in 2026 by Ann Arbor SPARK.

Ann Arbor, United States51–200Biotech, Genomics
Series B·$35.1M·May 2024
PersonalisIPO

Genomic sequencing company enabling precision oncology and cancer biomarker discovery for biophar...

Menlo Park, United States201–500Genomics, Life Sciences
Series C·$33.0M·Jan 2015
Form Bio

AI-driven platform for designing and optimizing genetic medicines and genome engineering for biot...

Austin, United States11–50Artificial Intelligence, Biotech
Series A·$30.0M·Sep 2022
Function Oncology

Develops a CRISPR-powered personalized functional genomics platform to profile patient tumors and...

San Diego, United States1–10Biotech, Diagnostics
Series A·$28.0M·Apr 2023